Community Healthcare Trust Incorporated (CHCT) Stock Price & Analysis
Community Healthcare Trust Incorporated (CHCT) closed at USD 12.93 on Thursday, October 22, 2026, up 2.29% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 12.93; the Oct 22, 2026 session ranged USD 12.76–13 on volume of 232,197 shares. Market capitalization is —, with a 52-week range of USD 12.58–19.17 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 12:27 UTC.
Also available as compact Markdown for AI agents: nexqual.com/CHCT.md
Key facts (CHCT)
- Last four reported quarters (through Jun 30, 2026): revenue $125M, net income $21.0M (16.8% margin), free cash flow $38.7M (SEC filings).
- 1 of 80 tracked superinvestors hold CHCT (13F, Q2 2026): 0 new, 0 added, 1 reduced, 0 unchanged.
- Insider open-market purchases, last ~7 months: 2 Form 4 filings, $273K; 0 by opportunistic insiders, 0 by routine insiders.
- Total return with dividends: 1Y +3.1% vs S&P 500 +14.9%; 5Y -59.3% vs S&P 500 +80.3%.
- Next earnings: 2026-11-03, EPS estimate USD —, revenue estimate $31.5M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (CHCT)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $90.6M | $97.7M | $113M | $116M | $121M | $125M |
| Net income | $22.5M | $22.0M | $7.7M | -$3.2M | $5.1M | $21.0M |
| EPS (diluted) | $0.87 | $0.81 | $0.20 | -$0.23 | $0.08 | — |
| Free cash flow | $49.1M | $49.9M | $42.4M | $34.2M | $35.9M | $38.7M |
| Net margin | 24.8% | 22.5% | 6.8% | -2.7% | 4.2% | 16.8% |
| Revenue growth | +19.7% | +7.8% | +15.5% | +2.6% | +4.7% | — |
| Cash + short-term investments | $2.4M | $11.2M | $3.5M | $4.4M | $3.3M | — |
| Total debt | $266M | $353M | $403M | $486M | $532M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (CHCT)
P/E at fiscal year-ends: Dec 2025 86.4x, Dec 2023 87.0x.
Superinvestors (SEC 13F-HR, Q2 2026) (CHCT)
1 of 80 tracked investors hold CHCT. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Christopher Davis | Davis Advisors | 0.03% | $5.9M | Reduced -2.2% |
Insider purchases (SEC Form 4, open-market, last ~7 months) (CHCT)
2 purchases, $273K. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.
| Trade date | Insider | Role | Shares | Value | Avg price | Insider type |
|---|---|---|---|---|---|---|
| 2026-08-14 | Dupuy David H. | CEO and President | 10,000 | $151K | 15.13 | Too little history (no open-market trades in 2023) |
| 2026-08-11 | Hensley Robert Z | Director | 8,000 | $122K | 15.21 | Too little history (no open-market trades in 2023 or 2025) |
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (CHCT)
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-12 | Piper Sandler | Target lowered | Neutral | $17 → $14 |
| 2026-10-09 | Truist Securities | Target lowered | Buy | $18 → $17 |
| 2026-09-21 | Evercore ISI Group | Target lowered | In-Line | $18 → $17 |
| 2026-08-06 | Piper Sandler | Target lowered | Neutral | $20 → $17 |
| 2026-08-06 | Evercore ISI Group | Target raised | In-Line | $17 → $18 |
| 2026-07-21 | Piper Sandler | Target raised | Neutral | $18 → $20 |
Total return (dividends reinvested) (CHCT)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +3.1% | -59.3% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +3.1% | -16.4% |
| Volatility (annualized) | 28.1% | 31.1% |
| Max drawdown | -32.0% (Jul 2026→Oct 2026) | -63.3% (Jan 2022→Oct 2025) |
CHCT company outlook (results filed Aug 4, 2026)
- “Key strategic priorities for the next 18-24 months include occupancy improvement to 92%, portfolio reinvestment with 9-12% yields on capital, strategic capital recycling with over $70 million of marketed dispositions, and acquisition growth beginning with the current $99 million high-quality pipeline under contract with 9-10% expected yields and approximately 2.5% escalators.”
- “Reallocating this capital is expected to provide an additional $25 million to $30 million of retained capital over the next two years to fund accretive acquisitions, portfolio reinvestments, and occupancy improvements.”
- “While the transaction is progressing, the Company cannot provide assurance regarding the specific timing or the ultimate certainty of the closing. 1 • The Company has four properties under definitive purchase agreements, to be acquired after completion and occupancy, for an aggregate expected purchase price of approximately $99.0 million.”
- “The Company's expected returns on these investments are approximately 9.1% to 9.75%.”
Quoted word-for-word from the SEC 8-K results press release.
CHCT analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | — | — | — | $31.5M | — |
| Next quarter (ends Dec 2026) | — | — | — | $32.1M | — |
| Current fiscal year (ends Dec 2026) | — | — | — | $126.3M | — |
| Next fiscal year (ends Dec 2027) | — | — | — | $132.9M | — |
CHCT options: expected move
Options price a move of about ±8.9% (±$1.15) by Nov 20, 2026, which includes earnings on Nov 3, 2026. Over the last 8 reports the stock moved ±5.5% on average.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 28 | 37.0% | ±8.9% |
| Dec 18, 2026 | 56 | 32.8% | ±10.4% |
| Jan 15, 2027 | 84 | 40.7% | ±15.7% |
| Apr 16, 2027 | 175 | 32.8% | ±17.8% |
30-day implied volatility 33% vs 25.9% realized over the last 30 trading days. Put/call ratio (volume) 0.31. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 12:27 UTC)
| Price | USD 12.93 |
|---|---|
| Change | ▲ 2.29% (up) |
| Previous Close | USD 12.93 |
| Open | USD 12.93 |
| Day Range | USD 12.76 – 13 |
| 52-Week Range | USD 12.58 – 19.17 |
| Volume | 232,197 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (CHCT)
Nexqual's technical model rates CHCT "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of October 23, 2026 at 12:27 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 35.1 (neutral) |
| vs SMA50 | Below (USD 14.27) |
| MACD | -0.45 (negative) |
Earnings (CHCT)
| Next Earnings Date | 2026-11-03 |
|---|---|
| Revenue Estimate | $31.53M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2025-09-30 | USD 0.09 vs est 0.08 ▲ beat |
Source: Nexqual, October 23, 2026 at 12:27 UTC.
Financials & Fundamentals (CHCT)
| Total Revenue | $124.78M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +7.40% |
| Gross Margin | +80.62% |
| Operating Margin | +31.16% |
| Profit Margin | +16.81% |
| ROE | +4.93% |
| Debt / Equity | 1.36 |
| Current Ratio | 3.03 |
| Total Cash | $11.72M |
| Total Debt | $563.30M |
Source: Nexqual, October 23, 2026 at 12:27 UTC.
Ownership (CHCT)
| Insider Ownership | +6.42% |
|---|---|
| Institutional Ownership | +84.30% |
| Shares Outstanding | 28.65M |
| Float | 25.22M |
| Short % of Float | +3.51% |
Source: Nexqual, October 23, 2026 at 12:27 UTC.
From Community Healthcare Trust Incorporated's Latest SEC 10-K Filing (filed 2026-02-17)
Key Strengths & Strategy (as disclosed to the SEC)
- As of December 31, 2025, we had gross investments of approximately $1.2 billion in 198 real estate properties (including one property, with sales-type leases, with a gross amount totaling approximately $8.1 million and one property classified as held for sale with a net investment totaling approximately $5.3 million).
- We believe that we are organized in conformity with the requirements for qualification as a REIT under the Code and that our manner of operations will enable us to continue to meet the requirements for qualification and taxation as a REIT for U.S. federal income tax purposes for the year ending December 31, 2026.
Partnerships
- Our tenant base includes many nationally recognized healthcare providers (or their affiliates) and our property portfolio has significant diversification with respect to healthcare provider, industry segment, and facility type. •Attractive and Disciplined Investment Focus.
- We currently have no intention to invest in companies that provide healthcare services structured to comply with the REIT Investment Diversification and Empowerment Act of 2007, or RIDEA.
Legal & Regulatory Risks (Item 1A, quoted)
- Our tenants are subject to significant regulatory oversight, and changes in any of the laws and regulations applicable to their business could adversely impact our tenants' ability to make rent payments to us, which, in turn, could have a material adverse effect on our business, revenues, results of operations and financial conditions.
- Changes to U.S. tariff and import/export regulations may have an adverse effect on our business, financial condition and results of operations.
- The healthcare industry is heavily regulated and new laws or regulations, changes to existing laws or regulations, changes to reimbursement models or structure, loss of licensure or failure to obtain licensure could adversely impact our company and result in the inability of our tenants to make rent payments to us.
- Our tenants and our Company are subject to fraud and abuse laws, the violation of which by a tenant may jeopardize the tenant's ability to make rent payments to us.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| XRN | Chiron Real Estate Inc. | USD 30.16 | ▲ 4.61% |
| UHT | Universal Health Realty Income | USD 37.81 | ▲ 2.41% |
| MPT | Medical Properties Trust, Inc. | USD 2.71 | ▲ 3.04% |
| DHC | Diversified Healthcare Trust | USD 7.87 | ▲ 2.34% |
| LTC | LTC Properties, Inc. | USD 43.33 | ▲ 2.7% |
| NHI | National Health Investors, Inc. | USD 66.96 | ▲ 3.14% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 12:27 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt